Rebound pustular psoriasis after brodalumab discontinuation

被引：18

作者：

Khemis, A. ^{[1
]}

Cavalie, M. ^{[1
]}

Montaudie, H. ^{[1
]}

Lacour, J. -P. ^{[1
]}

Passeron, T. ^{[1
,2
]}

机构：

[1] Univ Hosp Nice, Dept Dermatol, F-06200 Nice, France

[2] INSERM, U1065, Team 12, C3M, Nice, France

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2016年 / 175卷 / 05期

关键词：

D O I：

10.1111/bjd.14627

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：1065 / 1066

页数：2

共 7 条

[1] Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials [J].

Griffiths, Christopher E. M. ;

Reich, Kristian ;

Lebwohl, Mark ;

van de Kerkhof, Peter ;

Paul, Carle ;

Menter, Alan ;

Cameron, Gregory S. ;

Erickson, Janelle ;

Zhang, Lu ;

Secrest, Roberta J. ;

Ball, Susan ;

Braun, Daniel K. ;

Osuntokun, Olawale O. ;

Heffernan, Michael P. ;

Nickoloff, Brian J. ;

Papp, Kim .

LANCET, 2015, 386 (9993) :541-551

[2] Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials [J].

Langley, Richard G. ;

Elewski, Boni E. ;

Lebwohl, Mark ;

Reich, Kristian ;

Griffiths, Christopher E. M. ;

Papp, Kim ;

Puig, Lluis ;

Nakagawa, Hidemi ;

Spelman, Lynda ;

Sigurgeirsson, Bardur ;

Rivas, Enrique ;

Tsai, Tsen-Fang ;

Wasel, Norman ;

Tyring, Stephen ;

Salko, Thomas ;

Hampele, Isabelle ;

Notter, Marianne ;

Karpov, Alexander ;

Helou, Silvia ;

Papavassilis, Charis .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (04) :326-338

[3] Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis [J].

Lebwohl, M. ;

Strober, B. ;

Menter, A. ;

Gordon, K. ;

Weglowska, J. ;

Puig, L. ;

Papp, K. ;

Spelman, L. ;

Toth, D. ;

Kerdel, F. ;

Armstrong, A. W. ;

Stingl, G. ;

Kimball, A. B. ;

Bachelez, H. ;

Wu, J. J. ;

Crowley, J. ;

Langley, R. G. ;

Blicharski, T. ;

Paul, C. ;

Lacour, J. -P. ;

Tyring, S. ;

Kircik, L. ;

Chimenti, S. ;

Duffin, K. C. ;

Bagel, J. ;

Koo, J. ;

Aras, G. ;

Li, J. ;

Song, W. ;

Milmont, C. E. ;

Shi, Y. ;

Erondu, N. ;

Klekotka, P. ;

Kotzin, B. ;

Nirula, A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (14) :1318-1328

[4]

Papp K, 2015, AM AC DERM ANN M SAN, V12, pP275

[5] Safety and efficacy of brodalumab for psoriasis after 120 weeks of treatment [J].

Papp, Kim ;

Leonardi, Craig ;

Menter, Alan ;

Thompson, Elizabeth H. Z. ;

Milmont, Cassandra E. ;

Kricorian, Greg ;

Nirula, Ajay ;

Klekotka, Paul .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (06) :1183-U399

[6] A case of generalized psoriasiform and pustular eruption induced by infliximab: evidence for skin-homing Th17 in the pathogenesis [J].

Teraki, Y. ;

Tanaka, S. ;

Hitomi, K. ;

Izaki, S. .

BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (06) :1347-1351

[7] Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis [J].

Yilmaz, Senem Buyukkara ;

Cicek, Nilufer ;

Coskun, Mesut ;

Yegin, Olcay ;

Alpsoy, Erkan .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 2012, 304 (06) :465-469

← 1 →